<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>klinik sonuçlar** &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/klinik-sonuclar/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 23 Jan 2026 09:22:15 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>klinik sonuçlar** &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Combining Intralesional Immunotherapy for Verruca Treatment</title>
		<link>https://bioengineer.org/combining-intralesional-immunotherapy-for-verruca-treatment/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jan 2026 09:21:48 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[combination therapy]]></category>
		<category><![CDATA[HPV tedavisi]]></category>
		<category><![CDATA[HPV treatment]]></category>
		<category><![CDATA[İşte 5 uygun etiket: **intralesional immunotherapy]]></category>
		<category><![CDATA[İşte 5 uygun etiket: **intralezyonel immünoterapi]]></category>
		<category><![CDATA[klinik sonuçlar**]]></category>
		<category><![CDATA[kombine dermatoloji tedavileri]]></category>
		<category><![CDATA[siğil tedavisi]]></category>
		<category><![CDATA[wart treatment]]></category>
		<guid isPermaLink="false">https://bioengineer.org/combining-intralesional-immunotherapy-for-verruca-treatment/</guid>

					<description><![CDATA[In a groundbreaking study led by Nofal et al., researchers have delved into the intricate world of dermatology, focusing particularly on multiple verrucae, commonly known as warts. This research has brought to light a promising approach to treatment by examining the efficacy of combined intralesional immunotherapy. The project’s core hypothesis posits that amalgamating different therapeutic [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">319716</post-id>	</item>
		<item>
		<title>Hemodynamically Significant PDA Worsens Outcomes in BPD Infants</title>
		<link>https://bioengineer.org/hemodynamically-significant-pda-worsens-outcomes-in-bpd-infants/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 17 Jan 2026 16:55:49 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[Bronkopulmoner displazi]]></category>
		<category><![CDATA[klinik sonuçlar**]]></category>
		<category><![CDATA[Multicenter çalışma]]></category>
		<category><![CDATA[PDA]]></category>
		<category><![CDATA[Prematüre bebekler]]></category>
		<guid isPermaLink="false">https://bioengineer.org/hemodynamically-significant-pda-worsens-outcomes-in-bpd-infants/</guid>

					<description><![CDATA[In the complex realm of neonatal medicine, two of the most pressing challenges confronting clinicians are bronchopulmonary dysplasia (BPD) and hemodynamically significant patent ductus arteriosus (hsPDA), particularly in the extremely preterm infant population. These conditions, individually known to complicate the fragile physiology of neonates born far before term, have long been studied for their impact [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">317790</post-id>	</item>
		<item>
		<title>Revolutionizing Pancreatic Cancer Surgery: SBRT and Intraoperative EBT</title>
		<link>https://bioengineer.org/revolutionizing-pancreatic-cancer-surgery-sbrt-and-intraoperative-ebt/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 22 Dec 2025 23:11:35 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[intraoperatif radyoterapi]]></category>
		<category><![CDATA[İşte 5 uygun etiket: **pankreas kanseri tedavisi]]></category>
		<category><![CDATA[klinik sonuçlar**]]></category>
		<category><![CDATA[neoadjuvant tedavi]]></category>
		<category><![CDATA[stereotaktik vücut radyoterapisi (SBRT)]]></category>
		<guid isPermaLink="false">https://bioengineer.org/revolutionizing-pancreatic-cancer-surgery-sbrt-and-intraoperative-ebt/</guid>

					<description><![CDATA[In a significant advancement in the treatment of pancreatic cancer, researchers have explored the efficacy of neoadjuvant stereotactic body radiation therapy (SBRT) paired with intraoperative electron radiotherapy during surgical resection. This innovative approach aims to enhance treatment outcomes for one of the most challenging malignancies known for its lethality. The study, spearheaded by Cornejo and [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">310438</post-id>	</item>
	</channel>
</rss>
